1. Signaling Pathways
  2. Stem Cell/Wnt
    TGF-beta/Smad
  3. RUNX
  4. RUNX2 Isoform

RUNX2

RUNX2 (Runt-related transcription factor 2) is a master transcription factor that governs osteoblast differentiation, bone formation, and skeletal development by regulating osteogenic gene expression programs[1][2]. RUNX2 functions early during mesenchymal stem cell commitment to the osteoblast lineage and remains essential for progression through multiple stages of osteogenesis, while its expression is tightly controlled during osteoblast maturation[3][4]. Mechanistically, RUNX2 integrates signals from developmental and intracellular pathways, including MAPK-mediated activation and BMP-2/SMAD signaling, to coordinate transcriptional programs required for bone matrix production and mineralization[5][6]. RUNX2 also participates in chondrocyte maturation and endochondral bone development, highlighting its central role in skeletal tissue formation beyond osteoblast biology[3][7]. In disease and experimental models, loss of RUNX2 function causes profound skeletal abnormalities, and RUNX2 deficiency in mice results in the absence of osteoblasts and impaired bone formation, establishing RUNX2 as an indispensable regulator of skeletal development[3][8]. In humans, heterozygous mutations in RUNX2 cause cleidocranial dysplasia, a hereditary skeletal disorder characterized by defects in bone development[8][9]. Compared with related RUNX family members, RUNX2 exhibits a specialized role in osteoblast lineage specification and bone-forming activity, although partial functional overlap with RUNX3 has been reported during chondrocyte maturation[3]. Two major RUNX2 isoforms have been described, with evidence indicating distinct contributions to osteoblast development, where type I is associated with early osteoblastogenesis and type II contributes to later stages of osteoblastic maturation[10]. For experimental applications, RUNX2 activity is widely used as a molecular indicator of osteogenic differentiation, and modulation of BMP-2 signaling can alter RUNX2 expression in osteoblast models, providing a useful framework for studying bone formation mechanisms[6].

RUNX2 Related Products (6):

Cat. No. Product Name Effect Purity
  • HY-P5832
    BMP2-derived peptide
    Activator 98.04%
    BMP2-derived peptide is an osteogenic inducer and BMP receptor ligand. BMP2-derived peptide binds to BMP receptors on the cell surface to form a complex, activates the downstream Smad signaling pathway, and regulates the expression of osteogenic transcription factors. BMP2-derived peptide effectively promotes the adhesion, proliferation, osteogenic differentiation and mineralization of bone marrow mesenchymal stem cells, significantly up-regulates the mRNA levels of OCN, Runx2 and type I collagen, and increases alkaline phosphatase activity and calcium deposition. BMP2-derived peptide induces osteoblast differentiation and ectopic bone regeneration, and improves cranial bone defect repair. Meanwhile, BMP2-derived peptide enhances the cytocompatibility of mesoporous silica nanoparticles, synergistically increases osteogenic activity with Dexamethasone (HY-14648), serving as an important tool for bone defect repair research.
  • HY-107245
    Segetalin B
    Activator 99.56%
    Segetalin B, an orally active cyclopentapeptide found in Vaccaria segetalis, possesses estrogen-like activity. Segetalin B promotes mineralization of ovariectomized rat-derived bone marrow mesenchymal stem cells (BMSCs) in vitro and increases the level of osteocalcin, BMP-2, ALP, and SIRT1 activity. Segetalin B is promising for research of post-menopausal osteoporosis (PMOP).
  • HY-W014410
    Mucic acid
    Activator 99.36%
    Mucic acid is an aldonic acid that can be prepared from pectin. Mucic acid increases the expression level of Runx2, promotes osteoblast differentiation, and upregulates osteogenic differentiation marker genes. Mucic acid can be used to prepare platform compounds, polymers, polymer materials and metal-organic frameworks. Mucic acid is applicable to the research of bone-related defects.
  • HY-W019901B
    Anhydrous calcium sulfate (97%)
    Activator 99.40%
    Anhydrous calcium sulfate (97%) serves as an oil-based drilling fluid additive and an osteogenic material. Anhydrous calcium sulfate (97%) increases the plastic viscosity, yield point, apparent viscosity and gel strength of oil-based drilling fluids. Anhydrous calcium sulfate (97%) upregulates the expression of bone-related genes FOSL1, RUNX2 and SPP1. Anhydrous calcium sulfate (97%) significantly affects the behavior of dental pulp stem cells, enhancing their proliferation, differentiation and matrix deposition.
  • HY-W115785
    Zinc borate
    Activator
    Zinc borate is a bioactive inorganic substance with properties including osteogenic induction, pro-angiogenesis, antioxidation, antimutagenesis and cytotoxicity. In the field of bone tissue engineering, Zinc borate is often incorporated into chitosan scaffolds. By releasing zinc ions and borate ions, Zinc borate induces the differentiation of human dental pulp stem cells into osteoblasts, upregulates the expression of bone-related genes and promotes calcium deposition. Zinc borate also promotes angiogenesis by upregulating key factors such as vascular endothelial growth factor. Zinc borate exhibits antioxidant capacity to scavenge free radicals, and can specifically reduce mutagenicity under specific conditions. Zinc borate reduces the survival rate of mouse fibroblasts, but it can still be used in studies related to bone tissue engineering.
  • HY-W014410R
    Mucic acid (Standard)
    Activator
    Mucic acid (Standard) is the analytical standard of Mucic acid (HY-W014410). This product is intended for research and analytical applications. Mucic acid is an aldonic acid that can be prepared from pectin. Mucic acid increases the expression level of Runx2, promotes osteoblast differentiation, and upregulates osteogenic differentiation marker genes. Mucic acid can be used to prepare platform compounds, polymers, polymer materials and metal-organic frameworks. Mucic acid is applicable to the research of bone-related defects.